Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment

Archive ouverte

Chatelain, Camille | Berland, Laurine | Grard, Marion | Jouand, Nicolas | Fresquet, Judith | Nader, Joëlle | Hirigoyen, Ugo | Petithomme, Tacien | Combredet, Chantal | Pons-Tostivint, Elvire | Fradin, Delphine | Treps, Lucas | Blanquart, Christophe | Boisgerault, Nicolas | Tangy, Frédéric | Fonteneau, Jean-François

Edité par CCSD ; Taylor & Francis -

International audience. Attenuated measles virus (MV) exerts its oncolytic activity in malignant pleural mesothelioma (MPM) cells that lack type-I interferon (IFN-I) production or responsiveness. However, other cells in the tumor microenvironment (TME), such as myeloid cells, possess functional antiviral pathways. In this study, we aimed to characterize the interplay between MV and the myeloid cells in human MPM. We cocultured MPM cell lines with monocytes or macrophages and infected them with MV. We analyzed the transcriptome of each cell type and studied their secretion and phenotypes by high-dimensional flow cytometry. We also measured transgene expression using an MV encoding GFP (MV-GFP). We show that MPM cells drive the differentiation of monocytes into M2-like macrophages. These macrophages inhibit GFP expression in tumor cells harboring a defect in IFN-I production and a functional signaling downstream of the IFN-I receptor, while having minimal effects on GFP expression in tumor cells with defect of responsiveness to IFN-I. Interestingly, inhibition of the IFN-I signaling by ruxolitinib restores GFP expression in tumor cells. Upon MV infection, cocultured macrophages express antiviral pro-inflammatory genes and induce the expression of IFN-stimulated genes in tumor cells. MV also increases the expression of HLA and costimulatory molecules on macrophages and their phagocytic activity. Finally, MV induces the secretion of inflammatory cytokines, especially IFN-I, and PD-L1 expression in tumor cells and macrophages. These results show that macrophages reduce viral proteins expression in some MPM cell lines through their IFN-I production and generate a pro-inflammatory interplay that may stimulate the patient’s anti-tumor immune response.

Suggestions

Du même auteur

Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells. Le virus oncolytique atténué de la rougeole codant pour NY-ESO-1 induit la présentation HLA I et II de cet antigène tumoral par le mélanome et les cellules dendritiques

Archive ouverte | Grard, Marion | CCSD

International audience. Antitumor virotherapy stimulates the antitumor immune response during tumor cell lysis induced by oncolytic viruses (OVs). OV can be modified to express additional transgenes that enhance the...

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus: Interferon genes loss sensitizes tumor cells to viral lysis

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience. Oncolytic immunotherapy is based on the use of non-pathogenic replicative oncolytic viruses (OV) that infect and kill exclusively tumor cells. Recently, we showed that the spontaneous oncolyt...

Chargement des enrichissements...